STADA Arzneimittel AG is an international publicly-listed company. At the center of the business activities are the pharmaceutical and, in particular, the generics market with sustainable growth potential.
STADA is currently represented worldwide with 54 of its own sales companies in 33 countries. At the same time, Germany remains the largest national market for STADA. Outside of Europe STADA has a total of six sales companies.
Here you have the opportunity to follow the STADA Conference Call for the first quarter of 2012 with STADA´s Executive Board live on May 10, 2012.
STADA's Annual General Meeting 2012 will take place on May 30, 2012 at the Congress Center Messe in Frankfurt am Main. Please follow the link where we have compiled important information for you.
Here you will find contact persons from the Investor Relations area.
Here you can find the members of the Executive Board of the Supervisory Board and of the Advisory Board.